Evidence map›Paper›PMID 19166506›Full record

ArticleJournal of neurochemistry2009

Essential roles of dopamine D4 receptors and the type 1 adenylyl cyclase in photic control of cyclic AMP in photoreceptor cells.

Chad R Jackson, Shyam S Chaurasia, Hong Zhou, Rashidul Haque, Daniel R Storm, P Michael Iuvone

Open access · greenAbstract readComparative Study
In one paragraph

Article in Journal of neurochemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 60 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Retardation of myopia by atropine regimes.International journal of ophthalmology · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Rhodopsin-mediated light-off-induced protein kinase A activation in mouse rod photoreceptor cells.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  10. Circadian regulation in the retina: From molecules to network.The European journal of neuroscience · 2020
    Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. The Retina and Other Light-sensitive Ocular Clocks.Journal of biological rhythms · 2016
    Review
  17. Article
  18. Article
  19. Article
  20. Role of dopamine in distal retina.Journal of comparative physiology. A, Neuroethology, sensory, neural, and behavioral physiology · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Chad R JacksonDepartment of Pharmacology, Emory University School of Medicine, Atlanta, Georgia 30322, USA.
Shyam S Chaurasia
Hong Zhou
Rashidul Haque
Daniel R Storm
P Michael Iuvone
Emory University · USCleveland Clinic · USUniversity of Washington · US

Funding

P30-Core Grant for Vision Research Core CP30EY006360 · NEI · EMORY UNIVERSITY · PI BOATRIGHT, JEFFREY H · 1986 to 2025
$15.3M
Neuromodulators and Circadian Clocks: Roles in Retinal Function and DysfunctionR01EY004864 · NEI · EMORY UNIVERSITY · PI IUVONE, P MICHAEL · 1985 to 2018
$7.0M
VIsion Science Training in AtlantaT32EY007092 · NEI · EMORY UNIVERSITY · PI Machelle T. Pardue · 1985 to 2026
$4.6M
Neuromodulators and Signaling Cascades in RetinaR01EY014764 · NEI · EMORY UNIVERSITY · PI IUVONE, P MICHAEL · 2004 to 2007
$1.4M
NEI NIH HHS P30 EY006360NEI NIH HHS P30EY006360NEI NIH HHS R01 EY004864NEI NIH HHS R01EY004864NEI NIH HHS R01 EY014764NEI NIH HHS R01EY014764NEI NIH HHS T32 EY007092NEI NIH HHS T32EY007092
6 · The paper itself

Abstract

Light and dopamine regulate many physiological functions in the vertebrate retina. Light exposure decreases cyclic AMP formation in photoreceptor cells. Dopamine D(4) receptor (D(4)R) activation promotes light adaptation and suppresses the light-sensitive pool of cyclic AMP in photoreceptor cells. The key signaling pathways involved in regulating cyclic AMP in photoreceptor cells have not been identified. In the present study, we show that the light- and D(4)R-signaling pathways converge on the type 1 Ca(2+)/calmodulin-stimulated adenylyl cyclase (AC1) to regulate cyclic AMP synthesis in photoreceptor cells. In addition, we present evidence that D(4)R activation tonically regulates the expression of AC1 in photoreceptors. In retinas of mice with targeted deletion of the gene (Adcy1) encoding AC1, cyclic AMP levels and Ca(2+)/calmodulin-stimulated adenylyl cyclase activity are markedly reduced, and cyclic AMP accumulation is unaffected by either light or D(4)R activation. Similarly, in mice with disruption of the gene (Drd4) encoding D(4)R, cyclic AMP levels in the dark-adapted retina are significantly lower compared to wild-type retina and are unresponsive to light. These changes in Drd4-/- mice were accompanied by significantly lower Adcy1 mRNA levels in photoreceptor cells and lower Ca(2+)/calmodulin-stimulated adenylyl cyclase activity in retinal membranes compared with wild-type controls. Reduced levels of Adcy1 mRNA were also observed in retinas of wild-type mice treated chronically with a D(4)R antagonist, L-745870. Thus, activation of D(4)R is required for normal expression of AC1 and for the regulation of its catalytic activity by light. These observations illustrate a novel mechanism for cross-talk between dopamine and photic signaling pathways regulating cyclic AMP in photoreceptor cells.

Indexed as

Adenylyl CyclasesAnimalsCatalysisCyclic AMPDopamine AntagonistsMiceMice, Inbred C57BLMice, KnockoutPhotic StimulationPhotoreceptor CellsReceptors, Dopamine D4adenylyl cyclase 1Adenylyl CyclasesCyclic AMPDopamine AntagonistsReceptors, Dopamine D4

Identifiers

PMID19166506
PMCPMC2727872
OpenAlexW2071569046

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.